BIT 5.41% 3.9¢ biotron limited

Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-15

  1. 2,024 Posts.
    lightbulb Created with Sketch. 586
    POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV (BIT225-010)
     Preliminary analyses indicate that the primary objectives of the trial have been met.
    The results suggest that BIT225 is having a unique effect beyond that seen with current standard of
    care antiretroviral drugs.
     The data is consistent with BIT225 targeting virus present in reservoir cells.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.002(5.41%)
Mkt cap ! $35.18M
Open High Low Value Volume
4.0¢ 4.0¢ 3.8¢ $22.54K 592.1K

Buyers (Bids)

No. Vol. Price($)
3 618000 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 483271 5
View Market Depth
Last trade - 15.59pm 08/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.